D.E. Shaw & Co
ABUS icon

D.E. Shaw & Co’s Arbutus Biopharma ABUS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$126K Buy
+40,700
New +$126K ﹤0.01% 2874
2022
Q2
Sell
-19,698
Closed -$59K 4109
2022
Q1
$59K Sell
19,698
-3,202
-14% -$9.59K ﹤0.01% 3850
2021
Q4
$89K Buy
+22,900
New +$89K ﹤0.01% 3683
2019
Q3
Sell
-19,300
Closed -$40K 2523
2019
Q2
$40K Sell
19,300
-28,747
-60% -$59.6K ﹤0.01% 2533
2019
Q1
$172K Hold
48,047
﹤0.01% 2399
2018
Q4
$184K Sell
48,047
-12,509
-21% -$47.9K ﹤0.01% 2396
2018
Q3
$572K Sell
60,556
-409,952
-87% -$3.87M ﹤0.01% 2026
2018
Q2
$3.44M Sell
470,508
-239,954
-34% -$1.75M ﹤0.01% 1328
2018
Q1
$3.55M Sell
710,462
-495,663
-41% -$2.48M ﹤0.01% 1227
2017
Q4
$6.09M Sell
1,206,125
-547,980
-31% -$2.77M 0.01% 983
2017
Q3
$10.9M Buy
1,754,105
+19,576
+1% +$121K 0.02% 682
2017
Q2
$6.24M Sell
1,734,529
-12,573
-0.7% -$45.3K 0.01% 895
2017
Q1
$5.68M Buy
1,747,102
+12,499
+0.7% +$40.6K 0.01% 923
2016
Q4
$4.25M Buy
1,734,603
+13,622
+0.8% +$33.4K 0.01% 1050
2016
Q3
$5.92M Sell
1,720,981
-20,914
-1% -$71.9K 0.01% 878
2016
Q2
$6.06M Buy
1,741,895
+30,326
+2% +$106K 0.01% 885
2016
Q1
$7.07M Sell
1,711,569
-159,891
-9% -$660K 0.01% 819
2015
Q4
$8.33M Buy
1,871,460
+14,384
+0.8% +$64K 0.01% 720
2015
Q3
$11.3M Sell
1,857,076
-157,536
-8% -$959K 0.02% 619
2015
Q2
$23.9M Buy
2,014,612
+332,712
+20% +$3.95M 0.04% 428
2015
Q1
$29.4M Buy
1,681,900
+1,625,221
+2,867% +$28.4M 0.05% 353
2014
Q4
$859K Buy
56,679
+45,773
+420% +$694K ﹤0.01% 1773
2014
Q3
$231K Buy
+10,906
New +$231K ﹤0.01% 2139
2014
Q2
Hold
0
2316
2014
Q1
Hold
0
2290